This inventor holds 1 USPTO granted patent. Top assignee: Crown Bioscience, Inc. (Taicang). Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Man Zhou - Innovator in Antibody Development
Introduction
Man Zhou is a prominent inventor based in Taicang, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for treating diseases, including cancer.
Latest Patents
Man Zhou holds a patent for Anti-CTLA4 antibodies. This patent provides antibodies and antigen-binding fragments against CTLA4, which can block the binding of CTLA4 to its ligand. The antibodies disclosed in this patent offer potential agents for treating various diseases, especially cancer.
Career Highlights
Man Zhou is currently employed at Crown Bioscience, Inc. in Taicang. His role at the company allows him to engage in cutting-edge research and development in the field of antibody therapies. His expertise and innovative approach have positioned him as a key player in the biotechnology sector.
Collaborations
Man Zhou collaborates with talented professionals in his field, including Ziyong Sun and Wencui Ma. These collaborations enhance the research and development efforts at Crown Bioscience, Inc., fostering an environment of innovation and discovery.
Conclusion
Man Zhou's contributions to the development of Anti-CTLA4 antibodies exemplify his commitment to advancing medical science. His work not only highlights his innovative spirit but also underscores the importance of collaboration in achieving breakthroughs in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile